Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like Peptide 1 Receptor Agonists Promote Weight Loss Among People With Human Immunodeficiency Virus
Q. Nguyen, Darcy Wooten, Daniel Lee, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 4, pp. 978-982
Closed Access | Times Cited: 11

Showing 11 citing articles:

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel
Rajesh T. Gandhi, Raphael J. Landovitz, Paul E. Sax, et al.
JAMA (2024)
Closed Access | Times Cited: 6
Kidney disease in patients with HIV
Stephanie Mejia, Clara Fischman, Meghan E. Sise
Current Opinion in HIV and AIDS (2025)
Closed Access
Cardiometabolic health in people with HIV: expert consensus review
Rachel L. Batterham, Roger Bedimo, Ricardo Sobhie Diaz, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 6, pp. 1218-1233
Open Access | Times Cited: 4
Impact of Glucagon-like Peptide 1 Receptor Agonists on Body Weight in People with HIV and Diabetes Treated with Integrase Inhibitors
Dario Cattaneo, Anna Lisa Ridolfo, Andrea Giacomelli, et al.
Diabetology (2025) Vol. 6, Iss. 3, pp. 20-20
Open Access
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain
David Anderson, Moti Ramgopal, Debbie Hagins, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
Weight Gain and Antiretroviral Therapy
Samuel S. Bailin, John R. Koethe
Infectious Disease Clinics of North America (2024) Vol. 38, Iss. 3, pp. 499-515
Closed Access | Times Cited: 1
Analysis of drug-drug interactions in patients with HIV and metabolic syndrome
Jessica Tuan, Grace Igiraneza, Onyema Ogbuagu
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-13
Closed Access | Times Cited: 1
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention
Kathleen V. Fitch, Markella V. Zanni, Jennifer Manne‐Goehler, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 11, pp. 1449-1461
Closed Access | Times Cited: 1
Changes in hepatic steatosis before and after direct acting antiviral treatment in people living with HIV and Hepatitis C coinfection
Esther Truscello, Shouao Wang, Jim Young, et al.
The Journal of Infectious Diseases (2024)
Open Access
Optimizing Cardiometabolic Risk in People Living with Human Immunodeficiency Virus: A Deep Dive into an Important Risk Enhancer
Elizabeth A Kobe, Aarti Thakkar, Sarina Matai, et al.
American Journal of Preventive Cardiology (2024) Vol. 20, pp. 100888-100888
Open Access
Weighing In: Glucagon-Like Peptide-1 Receptor Agonism for Persons With HIV.
Teressa S Thomas, Suman Srinivasa
PubMed (2024) Vol. 32, Iss. 5, pp. 579-588
Closed Access
Page 1

Scroll to top